Buphenyl (Sodium Phenylbutyrate Tablets) and Omalizumab Subcutaneous
Determining the interaction of Buphenyl (Sodium Phenylbutyrate Tablets) and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: sodium phenylbutyrate
Brand name: Buphenyl
Synonyms: Buphenyl
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buphenyl (Sodium Phenylbutyrate Tablets)-Ombitasvir, Paritaprevir, and Ritonavir
- Buphenyl (Sodium Phenylbutyrate Tablets)-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Buphenyl (Sodium Phenylbutyrate Tablets)-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Buphenyl (Sodium Phenylbutyrate Tablets)-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Buphenyl (Sodium Phenylbutyrate Tablets)-Omeclamox-Pak
- Buphenyl (Sodium Phenylbutyrate Tablets)-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Bupivacaine
- Omalizumab Subcutaneous-Bupivacaine (Liposomal)
- Omalizumab Subcutaneous-Bupivacaine and Epinephrine
- Omalizumab Subcutaneous-Bupivacaine and Epinephrine Injection
- Omalizumab Subcutaneous-Bupivacaine Fisiopharma
- Omalizumab Subcutaneous-Bupivacaine Hydrochloride